SCINAI IMMUNOTHERAPEUTICS LTD
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.47
-9.05%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-64.0%
3 months
-82.7%
6 months
-93.3%
1 year
-96.8%
Year to date
-93.4%
52-week range
$0.47 – $14.60
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$300K
P/E
-0.1
P/B
0
P/S
0.2
Revenue
$1.49M
Net income
-$2.6M
Diluted EPS
—
Gross margin
-252.30%
Net margin
-174.80%
Return on equity
-26.50%
Total debt
$3.58M
Cash
$2.85M
Free cash flow
-$7.5M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $460K | -$2M | -272.20% | -435.40% | -$2.58M |
| Mar 31, 2026 | $489K | $3.58M | -228.60% | 731.50% | -$1.46M |
| Dec 31, 2025 | — | — | — | — | — |
| Jun 30, 2025 | — | — | — | — | — |
| Dec 31, 2024 | $206K | -$11.82M | -81.10% | -5738.80% | -$1.08M |
| Sep 30, 2024 | $168K | $10.46M | -148.20% | 6223.20% | -$2.04M |
| Jun 30, 2024 | $284K | -$2.32M | -57.70% | -817.60% | -$1.76M |
| Jun 30, 2024 | $284K | -$2.32M | -57.70% | -817.60% | -$1.76M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent SCNI news
All market newsNo ticker-linked stories are in the current archive.